Advertisement

The efficacy of cardiac shock wave therapy in the treatment of refractory angina: A pilot prospective, randomized, double-blind trial

Published:December 03, 2012DOI:https://doi.org/10.1016/j.ijcard.2012.11.099
      Refractory angina pectoris (RAP) is a growing clinical problem [
      • Mukherjee D.
      • Bhatt D.L.
      • Roe M.T.
      • Patel V.
      • Ellis S.G.
      Direct myocardial revascularization and angiogenesis — how many patients might be eligible.
      ]. Prognosis in these patients is poor and conventional medical therapy is frequently inadequate for symptom relief. The aim of this pilot prospective, double-blind, placebo-controlled study was to test the hypothesis that low-energy extracorporeal shockwave myocardial revascularization (ESMR) can reduce clinical symptoms and improve exercise tolerance in patients with RAP.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mukherjee D.
        • Bhatt D.L.
        • Roe M.T.
        • Patel V.
        • Ellis S.G.
        Direct myocardial revascularization and angiogenesis — how many patients might be eligible.
        Am J Cardiol. 1999; 84: 598-600
        • Aicher A.
        • Heeschen C.
        • Sasaki K.
        • et al.
        Low-energy shock wave for enhancing recruitment of endothelial progenitor cells.
        Circulation. 2006; 114: 2823-2830
        • Oi K.
        • Fukumoto Y.
        • Ito K.
        • et al.
        Extracorporeal shock wave therapy ameliorates hind limb ischemia in rabbits.
        Tohoku J Exp Med. 2008; 214: 151-158
        • Nishida T.
        • Shimokawa H.
        • Oi K.
        • et al.
        Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo.
        Circulation. 2004; 110: 3055-3061
        • Umatoku T.
        • Ito K.
        • Kohtaro A.
        • et al.
        Extracorporeal cardiac shock wave therapy improves left ventricular remodeling after acute myocardial infarction in pigs.
        Coron Artery Dis. 2007; 18: 397-404
        • Fu M.
        • Sun C.-K.
        • Lin Y.-C.
        • et al.
        Extracorporeal myocardial shockwave therapy reverses ischemia-related left ventricular dysfunction and remodelling: molecular cellular and functional assessment.
        PLoS One. 2011; 6: e24342
        • Fukumoto Y.
        • Ito A.
        • Uwatoku T.
        • et al.
        Extracorporeal cardiac shock wave therapy ameliorates myocardial ischemia in patients with severe coronary artery disease.
        Coron Artery Dis. 2006; 17: 63-70
        • Khattab A.A.
        • Broderson B.
        • Schuermann-Kuchenbrandt D.
        • et al.
        Extracorporeal cardiac shock wave therapy: first experience in everyday practice for the treatment of chronic refractory angina pectoris.
        Int J Cardiol. 2007; 121: 84-85
        • Kikuchi Y.
        • Ito K.
        • Ito Y.
        • et al.
        Double-blind and placebo-controlled study of the effectiveness and safety of extracorporeal cardiac shock wave therapy for severe angina pectoris.
        Circ J. 2010; 74: 589-591